Ambroxol alleviates hepatic ischemia reperfusion injury by antioxidant and antiapoptotic pathways.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Transplantation Proceedings

• Publication date

  2013-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.transproceed.2013.04.007PMID 23953561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Attenuation of reperfusion-induced hepatocyte apoptosis is associated with reversed bcl-2/bax ratio in hemi-hepatic artery-preserved portal occlusion.

  2012cited by this paper
• Matrine attenuates endotoxin-induced acute liver injury after hepatic ischemia/reperfusion in rats

  2011cited by this paper
• Exogenous phosphatidylethanolamine induces apoptosis of human hepatoma HepG2 cells via the bcl-2/Bax pathway.

  2009cited by this paper
• Protective effects of taurine against endotoxin-induced acute liver injury after hepatic ischemia reperfusion

  2009cited by this paper
• Antiinflammatory properties of ambroxol.

  2008cited by this paper
• Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in rats.

  2007cited by this paper
• Delivery of antioxidative enzyme genes protects against ischemia/reperfusion–induced liver injury in mice

  2006cited by this paper
• JNK mediates hepatic ischemia reperfusion injury.

  2005cited by this paper
• Glutathione Protects the Rat Liver Against Reperfusion Injury After Prolonged Warm Ischemia

  2004cited by this paper
• In vitro and in vivo antioxidant activity of ambroxol

  2004cited by this paper
• Mitogen-activated protein kinase pathways in redox signaling.

  2003cited by this paper
• Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection

  2003cited by this paper
• Cytoprotection against ischemia-induced DNA cleavages and cell injuries in the rat liver by pro-vitamin C via hydrolytic conversion into ascorbate

  2003cited by this paper
• Direct Activation of Mitochondrial Apoptosis Machinery by c-Jun N-terminal Kinase in Adult Cardiac Myocytes*

  2002cited by this paper
• Mechanism of hepatic ischemia/reperfusion injury and protection against reperfusion injury.

  2002cited by this paper
• Reactive species mechanisms of cellular hypoxia-reoxygenation injury.

  2002cited by this paper
• Novel Role for JNK as a Stress-activated Bcl2 Kinase*

  2001cited by this paper
• Signal transduction by the JNK group of MAP kinases.

  2000cited by this paper
• Protective effects of ambroxol in hypothermic liver preservation: a transplant study.

  2000cited by this paper
• Triggering and modulation of apoptosis by oxidative stress.

  2000cited by this paper
• Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver.

  1999cited by this paper
• Superoxide induces hepatocyte apoptosis during the early phase of reperfusion after murine liver ischemia.

  1998cited by this paper
• bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer.

  1998cited by this paper
• Donor pretreatment with ambroxol or dexamethasone fails to ameliorate reperfusion injury in experimental lung transplantation

  1998cited by this paper
• Antioxidant Function of Ambroxol in Mononuclear and Polymorphonuclear Cells in Vitro

  1997cited by this paper
• Zinc Is a Potent Inhibitor of the Apoptotic Protease, Caspase-3

  1997cited by this paper
• Oxidant scavenger function of ambroxol in vitro: a comparison withN-acetylcysteine

  1996cited by this paper
• The MAP kinase cascades are activated during post‐ischemic liver reperfusion

  1996cited by this paper
• Antioxidant properties of Ambroxol.

  1994cited by this paper
• Reactive oxygen and ischemia/reperfusion injury of the liver.

  1991cited by this paper
• Oxygen-derived free radicals in postischemic tissue injury.

  1985cited by this paper

• The protective effect of ambroxol against cyclophosphamide-induced acute kidney injury involves Nrf2/HO-1 signaling upregulation and suppression of oxidative and inflammatory damage.

  2026cites this paper
• Ambroxol mitigates renal ischemia/reperfusion-induced cardiac and renal injury via Nrf2/HO-1 activation and TLR4 pathway inhibition.

  2025cites this paper
• Protective effect of ambroxol on cyclophosphamide-induced intestinal damage: involvement of oxidative stress, inflammation, and Keap-1/Nrf2/HO-1 signaling

  2025influential citation
• Ambroxol mitigates cyclophosphamide-induced liver injury by suppressing TLR-4/NF-κB signaling and oxidative stress and upregulating cytoglobin, TXNRD1 and HMGB1

  2025cites this paper
• Ambroxol confers neuroprotection against scopolamine-induced Alzheimer’s-like pathology by modulating oxidative stress, neuroinflammation, and cognitive deficits via Nrf-2/JNK/GSK-3β signaling pathways

  2025cites this paper
• Unravelling the binding mode of ambroxol drug with DNA by biophysical, electrochemical and molecular dynamics simulation studies

  2025cites this paper
• Modulation of NF-κB/NLRP3 inflammasome axis Nrf2/HO-1 signaling and attenuation of oxidative stress mediate the protective effect of ambroxol against cyclophosphamide cardiotoxicity.

  2025cites this paper
• Ambroxol alleviates hippocampus injury after BRIR through suppression of the IRE1α/TRAF2 signaling pathway.

  2025cites this paper
• The evaluation of the protective effect of ambroxol against acetaminophen-induced hepatorenal toxicity in rats

  2024cites this paper
• Detection of Synergistic Interaction on an Additive Scale Between Two Drugs on Abnormal Elevation of Serum Alanine Aminotransferase Using Machine-Learning Algorithms

  2022cites this paper
• Effect and mechanism of propofol in hepatic ischemia/reperfusion injury of rat.

  2021cites this paper
• Use of natural anti-oxidants in experimental animal models of hepatic ischemia-reperfusion injury

  2020cites this paper
• Ambroxol attenuates cisplatin-induced hepatotoxicity and nephrotoxicity via inhibition of p-JNK/p-ERK.

  2019cites this paper
• Perturbing Gangliosides In-vitro Using Ambroxol as a Treatment for Neurodegeneration

  2018influential citation
• Effect of ambroxol on experimentally induced acute oxidative stress in the heart, kidney, and intestine in rats

  2018cites this paper
• Effect and mechanism of propofol in hepatic ischemia/reperfusion injury of rat.

  2017cites this paper
• Preconditioning methods in the management of hepatic ischemia reperfusion‐ induced injury: Update on molecular and future perspectives

  2017cites this paper
• Ambroxol for the treatment of fibromyalgia: science or fiction?

  2017cites this paper
• Mehr als ein Expektorans: neue wissenschaftliche Daten zu Ambroxol im Kontext der Behandlung bronchopulmonaler Erkrankungen

  2017cites this paper
• Carvacrol Alleviates Ischemia Reperfusion Injury by Regulating the PI3K-Akt Pathway in Rats

  2014cites this paper